Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Cutaneous T-Cell Lymphoma

fingolimod hydrochloride has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bieber, T; Froehlich, A; Landsberg, J; Schmidt, S; Wenzel, J1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Cutaneous T-Cell Lymphoma

ArticleYear
Spontaneous regression of tumor-stage cutaneous T-cell lymphoma in a multiple sclerosis patient after discontinuing fingolimod.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2018, Volume: 24, Issue:13

    Topics: Adult; Fingolimod Hydrochloride; Humans; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Multiple Sclerosis; T-Lymphocytes

2018